Search

Advantage for One Stop Shop Julphar Has Chosen Ima Equipment for its New Plant in Saudi Arabia

| Editor: Anke Geipel-Kern

Starting from raw material transfer through closed systems, the production concept combines recipe management with minimal operator intervention, automated cleaning to avoid cross-contamination, and in-process control systems to ensure consistent product quality.

Related Companies

Granulation suite designed by Ima Active
Granulation suite designed by Ima Active
(Source: Fabio Baraldi)

Julphar Gulf Pharmaceutical Industries is one of the largest generic pharmaceutical manufacturer in the Middle East and North Africa. It produces over a million boxes of medicine daily, it holds 3,957 product registration certificates and it distributes medicine to over 40 countries. The company was established in 1980 in the United Arab Emirates (UAE) under the guidance of Sheikh Saqr bin Mohammed Al Qasimi, the emir of Ras al-KhaImah. Julphar’s first stand-alone facility made only five products. Over three decades later, Julphar operates 15 internationally certified manufacturing facilities globally, employs 3,000 people all over the world, and registered sales of AED 1.47 billion ($ 400 million) in 2015.

13 of Julphar’s facilities are based in the UAE, covering production areas including tablets, syrups and suspensions targeting the major therapeutic segments. Worthy of special mention is Julphar Diabetes, which is entirely dedicated to producing the active pharmaceutical ingredients (APIs) needed for insulin manufacture. Producing 1,500 kg/year of recombinant human insulin, equivalent to 40 million vials, Julphar Diabetes is among the largest manufacturers of insulin in the world and the only one of its kind in the Middle East.

Gallery

Local Company Gains Global Reach

“Julphar is an example of the United Arab Emirates’ local businesses making an impact on the global stage”, says Hasan Jibreel, the company’s Senior Director of Corporate Development. This impact, he explains, is the result of Julphar’s ongoing international expansion strategy.

After opening manufacturing facilities in Ethiopia and Bangladesh, Julphar is now close to completing a new facility in Saudi Arabia. “Emerging markets remain a key priority for sustainable growth”, says Jibreel, “since Julphar’s Middle Eastern roots allow us to reach difficult markets in a timely manner”.

Saudi Arabia was a logical choice for expansion, Jibreel says: “Saudi Arabia is our main market: more than 50% of our turnover comes from this area. Building this new factory is strategic for two main reasons. On one side, this new facility strengthens our presence in the Middle East and North Africa markets. On the other side, by opening this new plant Julphar complies with the new regulations in Saudi Arabia, which promote local manufacturers. This is just the first facility opening in the Gulf area. For sure, other projects will follow in the coming years”.

(ID:44177350)